Drug news
Luveniq is withdrawn from EMA for chronic non-infectious Uveitis
Lux Biosciences has withdrawn Luveniq (voclosporin oral) from the EMA as a treatment for chronic non-infectious Uveitis following a negative opinion from the CHMP which considered that the benefits of the drug did mnot outweight its risks.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.